From: Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival
No Cirrhosis (%) | Cirrhosis (%) | P-Value | |
---|---|---|---|
Sample Size | 2592 (71.1) | 1052 (28.9) | NA |
Facility Type | |||
Community Cancer Program | 76 (3.0) | 33 (3.2) | 0.127 |
Comprehensive Community Program | 495 (19.7) | 203 (19.8) | |
Academic/Research Program | 1579 (62.7) | 668 (65.3) | |
Integrated Network Cancer Program | 369 (14.7) | 119 (11.6) | |
Age, Median (IQR) | 66 (57–74) | 63 (57–70) | NA |
Age Categories | < 0.001 | ||
Non-Elderly (18–64 years old) | 1178 (45.5) | 597 (56.8) | |
Elderly (≥ 65 years old) | 1414 (54.6) | 455 (43.3) | |
Sex | < 0.001 | ||
Male | 1239 (47.8) | 703 (66.8) | |
Female | 1353 (52.2) | 349 (33.2) | |
Race | 0.034 | ||
White | 2146 (83.6) | 878 (84.3) | |
Black | 223 (8.7) | 105 (10.1) | |
Asian | 156 (6.1) | 40 (3.8) | |
Other | 41 (1.6) | 19 (1.8) | |
Ethnicity | < 0.001 | ||
Non-Hispanic | 2337 (92.5) | 901 (87.7) | |
Hispanic | 189 (7.5) | 127 (12.4) | |
Charlson Deyo Co-Morbidity Score | < 0.001 | ||
0 | 1722 (66.4) | 504 (47.9) | |
1 | 533 (20.6) | 239 (22.7) | |
2 | 189 (7.3) | 117 (11.1) | |
≥ 3 | 148 (5.7) | 192 (18.3) |